Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EP2163 / 2||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Aneurysm, Aortic stenosis, Cardiac arrest, Cardiac failure, Circulatory collapse, Haemorrhage intracranial, Heart rate, Hypokalaemia, Paraesthesia, Computerised tomogram head, Angiogram, Coma scale, Blood pressure measurement
Life Threatening? Yes
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: hypokalemia; aortal stenosis; intracranial hemorrhage; aneurysm; Heart arrest; Circulatory collapse; Heart failure; arm and leg tingling; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority with regulatory authority number: CZ-CZSUKL-21002747. An 81-year-old female patient received second dose of BNT162B2 (COMIRNATY, lot number: EP2163, exp date not reported), intramuscular on 17Feb2021 as single dose for COVID-19 immunisation. Medical history included Recto-sigmoidectomy on 2016 due to carcinoma, actinotherapy; Dilatation biliary tract, ongoing Cardiac valve disease (acquired valve disease according to the patient), ongoing Arterial hypertension wherein patient was on therapy, compensated; Ileus of intestine (small intestine loops) from Jun2020 to an unspecified date; ongoing Atrial fibrillation found out in Jun2020, unclear age, therapy with low molecular weight heparin was started, patient does not use it; Colitis most likely due to Crohn''s disease (in differential diagnosis there is radiation colitis associated with diverticulitis); ongoing after treatment of rectal cancer she suffered from persistent chronic diarrhoea and for this there was a regular replenishing minerals by infusion by a general practitioner (not specified); Pancreatic duct dilatation without obstructive liver enzymes elevation or inflammatory markers elevation, Ileal stenosis, inflammatory changes around the diverticles (diverticulitis), ongoing Oesophagitis grade II, on therapy with proton pump inhibitors, Stenosis of colon transversum and descendens; ongoing Gonarthrosis, Anorectal cancer from an unspecified date to an unspecified date gastroenterology care provided, there is no relapse of tumour according to CT scan and colonoscopy; Large intestine erosion/flat cecal lesion, there is no relapse of tumour according to CT scan and colonoscopy; ongoing Autoimmune thyroiditis in care of specialist. The patient had no known allergies, was a non-smoker and took alcohol occasionally. Concomitant medication included amlodipine besilate, indapamide, perindopril arginine (TRIPLIXAM), levothyroxine sodium (EUTHYROX), acetylsalicylic acid (ASPIRIN PROTECT), potassium chloride (KALNORMIN), rosuvastatin calcium (SORVASTA), omeprazole sodium (HELICID); all given orally, alprazolam (XANAX) and zolpidem. The patient previously took first dose of BNT162B2 (COMIRNATY, Lot number: EJ6797) via intramuscular route on 27Jan2021 for COVID-19 immunisation and did not notice any reaction. On 17Feb2021, after the second dose, the patient complained of arm and leg tingling - but because paresthesia was reported as a possible ADR, they did not pay attention. Shortly after midnight on 19Feb2021, the patient''s husband was awakened by a rattle, an ambulance was called to the patient for heart arrest (called by her husband) and cardiopulmonary resuscitation was initiated by laymen. The physicians continued the resuscitation and revived the patient by defibrillation and heart massage. Return of spontaneous circulation after 35 minutes in total, the first rhythm was asystole, epinephrine administered 3 times. For the whole time, Glasgow coma scale was 3. After successful revival, the patient was transferred to an Anesthesiology, resuscitation, and intensive care department. At the admission the circulation was effective, blood pressure 110/40 mmHg, and heart rate 97/min. Treatment of cardiac arrest: complex resuscitation care, KCl 7,45 %, Norepinephrine, Sufenta, Propofol, Kardegic, Trittico, Amoksiklav, Letrox, Controloc, Ondansetron, Degan, and Novalgin. After the admission patient was subdued and relaxed from the ambulance. On 19Feb2021 in the morning patient woke up able to make a contact, circulation stable. At 8:00 a.m. she was extubated. According to the attending physician, the most likely etiology of cardiac arrest is atrial tachyfibrillation with hypokalemia and aortal stenosis (onset date not reported). During the night from 19Feb2021 to 20Feb2021 there was a sudden episode of unconsciousness, with tongue swallowing and apnea and need of intubation. Check-up brain CT-scan with angiography showed a massive intracranial hemorrhage caused by an aneurysm in the area of vertebral arteries confluence and formation of a basilar artery. Conclusion of brain CT scan + angiography from 20Feb2021: massive intracranial hemorrhage caused by an aneurysm in the area of vertebral arteries confluence and formation of a basilar artery, basal cisterns filled up with blood, the blood is also present in both Sylvian fissures, along cerebral sulci on the brain convexity, also intrahemispherically and along the cerebellar tentorium (much more on the right side, where the aneurysm is). In all brain ventricles, there is a slightly major amount of blood. There is edema of the brain stem with almost complete compression of the fourth ventricle. Ectasia of middle cerebral artery bilaterally (medially). On 21Feb2021 there was an episode of hypertension and bradycardia, followed by a cardiac and circulatory arrest. On 21Feb2021 at 13:15 the patient died due to cardiac and circulatory arrest. Autopsy was not performed. The patient recovered from heart arrest on 19Feb2021 while the outcome of other events was unknown. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: cardiac and circulatory arrest; cardiac and circulatory arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166